Volgograd State Medical University is located in Volgograd which is situated in the southern part of Russia on the west bank of the Volga River. It started as Stalingrad Medical Institute founded in 1935. In 1993 it received the status of the Academy, and in 2003 it was granted the status of the University.

During the past decade, Volgograd State Medical University conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 9 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 8 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Volgograd State Medical University" #1 sponsor was "Materia Medica Holding" with 8 trials, followed by "Italian Institute of Telemedicine" with 1 trials sponsored, "Takeda" with 1 trials sponsored, "Valenta Pharm JSC" with 1 trials sponsored and "Woerwag Pharma LLC" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Volgograd State Medical University" #1 collaborator was "BPLab" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Volgograd State Medical University" are "Obesity" (2 trials), "Acute Non-specific Low Back Pain" (1 trials), "Acute Respiratory Infection" (1 trials), "Acute Respiratory Viral Infections" (1 trials) and "Anxiety" (1 trials). Many other conditions were trialed in "Volgograd State Medical University" in a lesser frequency.

Most popular intervention types in "Volgograd State Medical University" are "Drug" (11 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Dietressa" (2 trials), "MMH-407" (2 trials), "Alogliptin Benzoate" (1 trials) and "Ambulatory blood pressure monitoring" (1 trials). Other intervention names were less common.

The vast majority of trials in "Volgograd State Medical University" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Volgograd State Medical University". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Volgograd State Medical University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Volgograd State Medical University, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".